Home » Topics » Regulatory » Patents

Patents
RSS

Korean laboratory prepares new series of TNF-alpha inhibitors

Nov. 4, 1998

Synthelabo team presents new agents for incontinence

Nov. 3, 1998

Preparation and use of TNF-alpha and MMP inhibitors described by Novartis

Nov. 3, 1998

Suntory describes new series for cardio- and cerebrovascular and peripheral circulatory disorders

Nov. 3, 1998

PTK inhibitors described by Knoll for immune and bone diseases

Nov. 3, 1998

Monoamine reuptake inhibitors especially useful for Parkinson's disease

Nov. 3, 1998

HMR presents new agents for lipid disorders

Nov. 2, 1998

New K+ channel blockers for arrhythmias, ulcers and related disorders

Nov. 2, 1998

Aminoacyl sulfamides synthesized at Cubist claimed for psoriasis

Nov. 2, 1998

Novel vitamin D compounds claimed for use in bone disorders and psoriasis

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...